🎯 check PD0325901 (Mirdametinib) product page
PD0325901 (Mirdametinib) is a potent, selective MEK1/2 inhibitor. It affects the MAPK/ERK signaling pathway by preventing ERK1/2 phosphorylation, effectively inhibiting cancer cell proliferation, migration, and inflammation, while promoting stem cell pluripotency.